PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Deals
WHO Brings Big Pharma Together to Fight Debilitating Diseases
A new report from WHO on overcoming the impact of neglected tropical diseases has spawned a $150 million funding and donation initiative from Big Pharma.
Last week, the World Health Organization (WHO) announced an initiative involving six Pharmaceutical companies—Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Bayer, and Eisai of Japan—that will bring much-needed funding and research to [...]
Pfizer to Acquire King Pharmaceuticals
The merger, announced on Tuesday, will cost Pfizer $3.6 billion.
Pfizer and King Pharmaceuticals announced on Tuesday they have entered into a definitive friendly merger agreement. Under the terms, Pfizer will acquire King, a diversified specialty pharmaceutical company based in Tennessee, for $3.6 billion in cash, or $14.25 per share. The company emphasized the deal is not [...]
Affordable Access to HIV Meds on the Way
UNITAID’s Medicines Patent Pool seeks to bring costly HIV/AIDS treatments and other essential drugs to low-income countries by requiring patent-holders to license their technologies to generics manufacturers. Will pledges of support from the NIH bring some of these patent-holders back to the negotiating table?
A new way for patients to have access to affordable HIV and [...]
Endo Pharmaceuticals Acquires Qualitest for $1.2 Billion
The biotech aims to deliver more comprehensive healthcare solutions across its diversified businesses in branded pharmaceuticals, generics, and devices & services in key therapeutic areas with this deal.
Endo Pharmaceuticals has entered into an agreement to acquire privately held Qualitest Pharmaceuticals for approximately $1.2 billion in cash.
Qualitest, the sixth-largest US generics company as measured by [...]
Fixing Biotech's Broken Business Model